Búsqueda | Portal de Búsqueda de la BVS España

1.

Diagnostic exome sequencing in early-onset Parkinson's disease confirms VPS13C as a rare cause of autosomal-recessive Parkinson's disease.

Schormair, B; Kemlink, D; Mollenhauer, B; Fiala, O; Machetanz, G; Roth, J; Berutti, R; Strom, T M; Haslinger, B; Trenkwalder, C; Zahorakova, D; Martasek, P; Ruzicka, E; Winkelmann, J.

Clin Genet; 93(3): 603-612, 2018 03.

Artículo en Inglés | MEDLINE | ID: mdl-28862745

2.

Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.

Fengler, S; Roeske, S; Heber, I; Reetz, K; Schulz, J B; Riedel, O; Wittchen, H U; Storch, A; Linse, K; Baudrexel, S; Hilker, R; Mollenhauer, B; Witt, K; Schmidt, N; Balzer-Geldsetzer, M; Dams, J; Dodel, R; Gräber, S; Pilotto, A; Petrelli, A; Fünkele, S; Kassubek, J; Kalbe, E.

Psychol Med; 46(11): 2275-86, 2016 08.

Artículo en Inglés | MEDLINE | ID: mdl-27193073

3.

[Early recognition of Parkinson's disease. Objectifiable non-motor symptoms and biomarkers]. / Früherkennung der Parkinson-Krankheit. Objektivierbare nichtmotorische Symptome und Biomarker.

Mollenhauer, B; Sixel-Döring, F; Storch, A; Schneider, C; Hilker, R; Kalbe, E.

Nervenarzt; 84(8): 918-26, 2013 Aug.

Artículo en Alemán | MEDLINE | ID: mdl-23831930

4.

Chaos theory and fractals.

Mollenhauer, B.

Aust Orthod J; Spec No: 9-21, 2017 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-29709113

5.

Disease modifying treatment trials in Parkinson's disease: how to balance expectations and interests of patients, physicians and industry partners?

Berg, D; Eggert, K; Haslinger, B; Kassubek, J; Mollenhauer, B; Reetz, K; Rogge, A; Schaeffer, E; Tönges, L; Zeuner, K E.

Neurol Res Pract; 2: 31, 2020.

Artículo en Inglés | MEDLINE | ID: mdl-33324933

6.

Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates.

Bourdenx, M; Nioche, A; Dovero, S; Arotcarena, M-L; Camus, S; Porras, G; Thiolat, M-L; Rougier, N P; Prigent, A; Aubert, P; Bohic, S; Sandt, C; Laferrière, F; Doudnikoff, E; Kruse, N; Mollenhauer, B; Novello, S; Morari, M; Leste-Lasserre, T; Damas, I Trigo; Goillandeau, M; Perier, C; Estrada, C; Garcia-Carrillo, N; Recasens, A; Vaikath, N N; El-Agnaf, O M A; Herrero, M T; Derkinderen, P; Vila, M; Obeso, J A; Dehay, B; Bezard, E.

Sci Adv; 6(20): eaaz9165, 2020 05.

Artículo en Inglés | MEDLINE | ID: mdl-32426502

7.

Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder.

Chahine, L M; Iranzo, A; Fernández-Arcos, A; Simuni, T; Seedorff, N; Caspell-Garcia, C; Amara, A W; Comella, C; Högl, B; Hamilton, J; Marek, K; Mayer, G; Mollenhauer, B; Postuma, R; Tolosa, E; Trenkwalder, C; Videnovic, A; Oertel, W.

NPJ Parkinsons Dis; 5: 2, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-30701189

8.

Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?

Mollenhauer, B; Bibl, M; Esselmann, H; Steinacker, P; Trenkwalder, C; Wiltfang, J; Otto, M.

J Neural Transm (Vienna); 114(7): 919-27, 2007 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-17318305

9.

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.

Otto, M; Wiltfang, J; Cepek, L; Neumann, M; Mollenhauer, B; Steinacker, P; Ciesielczyk, B; Schulz-Schaeffer, W; Kretzschmar, H A; Poser, S.

Neurology; 58(2): 192-7, 2002 Jan 22.

Artículo en Inglés | MEDLINE | ID: mdl-11805244

10.

An aligning auxiliary for ribbon arch brackets: rectangular boxes from ultrafine high tensile wires.

Mollenhauer, B.

Aust Orthod J; 11(4): 219-26, 1990 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-2152536

11.

Aminoterminally truncated and oxidized amyloid-beta peptide species in Alzheimer's disease.

Bibl, M; Esselmann, H; Mollenhauer, B; Wiltfang, J.

Neuroscience; 146(1): 17-8, 2007 Apr 25.

Artículo en Inglés | MEDLINE | ID: mdl-17317020

12.

Selective reduction of amyloid beta42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation.

Mollenhauer, B; Bibl, M; Esselmann, H; Steinacker, P; Trenkwalder, C; Brechlin, P; Wiltfang, J; Otto, M.

J Neurol Neurosurg Psychiatry; 77(10): 1201-3, 2006 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-16549413

13.

Swelling of Golgi apparatus of bovine mammary epithelial cells in response to monensin treatment requires fixation.

Morré, D J; Mollenhauer, H H; Spring, H; Trendelenburg, M; Montag, M; Mollenhauer, B A; Morré, D M.

Eur J Cell Biol; 57(2): 321-4, 1992 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-1511707

14.

Orthodontics and prevention.

Mollenhauer, B.

Aust Dent J; 23(4): 365-6, 1978 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-282844

15.

Iatrogenic diseases.

Mollenhauer, B.

Aust Dent J; 13(1): 91, 1968 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-5239084

16.

Stanley jacobs, 1939-2000

Mollenhauer B.

Am J Orthod Dentofacial Orthop; 117(4): 501, 2000 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-10756279

17.

New approaches to the Begg technique.

Mollenhauer, B.

Aust Orthod J; 10(4): 259-60, 1988 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-3273152

18.

Observability theory. Part II.

Mollenhauer, B.

Aust Orthod J; 10(3): 186-9, 195, 1988 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-3166622

19.

An expert system database for research design. Part I--Specifications.

Mollenhauer, B.

Aust Orthod J; 10(3): 190-5, 1988 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-3166623

20.

New approaches to the Begg technique. Part I--Qualitative aspects.

Mollenhauer, B.

Aust Orthod J; 10(2): 67-89, 1987 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-3333468

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Diagnostic exome sequencing in early-onset Parkinson's disease confirms VPS13C as a rare cause of autosomal-recessive Parkinson's disease.

Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.

[Early recognition of Parkinson's disease. Objectifiable non-motor symptoms and biomarkers]. / Früherkennung der Parkinson-Krankheit. Objektivierbare nichtmotorische Symptome und Biomarker.

Chaos theory and fractals.

Disease modifying treatment trials in Parkinson's disease: how to balance expectations and interests of patients, physicians and industry partners?

Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates.

Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder.

Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.

An aligning auxiliary for ribbon arch brackets: rectangular boxes from ultrafine high tensile wires.

Aminoterminally truncated and oxidized amyloid-beta peptide species in Alzheimer's disease.

Selective reduction of amyloid beta42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation.

Swelling of Golgi apparatus of bovine mammary epithelial cells in response to monensin treatment requires fixation.

Orthodontics and prevention.

Iatrogenic diseases.

Stanley jacobs, 1939-2000

New approaches to the Begg technique.

Observability theory. Part II.

An expert system database for research design. Part I--Specifications.

New approaches to the Begg technique. Part I--Qualitative aspects.